SUSQUEHANNA INTERNATIONAL GROUP, LLP - GEMINI THERAPEUTICS INC ownership

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 64 filers reported holding GEMINI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$27,000
-63.5%
16,600
-61.9%
0.00%
Q2 2022$74,000
+221.7%
43,602
+162.1%
0.00%
Q1 2022$23,000
-93.6%
16,633
-86.6%
0.00%
Q4 2021$360,000
-52.7%
123,710
-34.4%
0.00%
Q3 2021$761,000
+54.7%
188,632
+148.1%
0.00%
Q2 2021$492,000
-16.3%
76,026
+75.3%
0.00%
Q1 2021$588,00043,3610.00%
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 2,435,125$9,838,0003.06%
Asymmetry Capital Management, L.P. 284,079$1,148,0000.69%
Orbimed Advisors 5,826,224$23,538,0000.26%
Boxer Capital, LLC 1,300,000$5,252,0000.18%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,137,823$8,637,0000.15%
Ikarian Capital, LLC 421,050$1,701,0000.12%
JS Capital Management LLC 474,457$1,917,0000.11%
PURA VIDA INVESTMENTS, LLC 494,400$1,997,0000.06%
HARVARD MANAGEMENT CO INC 250,000$1,010,0000.06%
Atom Investors LP 102,792$415,0000.03%
View complete list of GEMINI THERAPEUTICS INC shareholders